0
2017
Antibody Drug Conjugates Market

Antibody Drug Conjugates Market

by Drugs (Adcetris and Kadcyla), Mechanism of Action (CD30 Antibodies and HER2 Antibodies), Application (Breast Cancer, Lymphoma, and Other Types of Cancer) - Global Opportunity Analysis and Industry Forecast 2017-2023.
Update Available On-Demand

✷  Report Code: A01148
Pages: 152
Sep 2017 | 15570 Views
Author(s) : Onkar S
Tables: 45
Charts: 37
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Antibody Drug Conjugates Market

Request Now !

Antibody Drug Conjugates Market Overview:

Antibody Drug Conjugates Market are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. ADC’s are designed to eliminate cancer cells only without harming the normal cells. This is a major advantage of ADC’s as the unharmed healthy cells enable patients to recover faster. The antibody drug conjugates market was valued at $1,387 million in 2016, and is estimated to reach $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023.

Antibody Drug Conjugates Market

The report segments the market based on drugs, technology, mechanism of action, application, and region. Based on drugs, the market is bifurcated into Adcetris and Kadcyla. Based on mechanism of action, it is classified into CD30 antibodies and HER2 antibodies. Based on application, the antibody drug conjugates market is categorized into breast cancer, lymphoma, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Global Antibody Drug Conjugates Market Segmentation

GLOBAL ANTIBODY DRUG CONJUGATES MARKET SEGMENTATION

Increase in prevalence of cancer worldwide and unhealthy urban lifestyle and surge in consumption of tobacco and alcohol across geographies pose as major cancer risk factors. According to National Cancer Institute “the number of people living beyond cancer diagnosis is expected to reach approximately 19 million by 2024.” Increase in demand for cost-effective and quality cancer treatment is expected to drive the ADC’s market during the study period.

Global Antibody Drug Conjugates Market, by Geography, 2016 (% Share)

GLOBAL ANTIBODY DRUG CONJUGATES MARKET, BY GEOGRAPHY, 2016 (% SHARE)

The report provides extensive competitive analysis and profiles of key market players, such as, include F. Hoffman-La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Seattle Genetics Inc., Genentech Inc., Immunogen Inc., Immunomedics, Inc., Progenics Pharmaceuticals Inc. and Bayer Healthcare Pharmaceuticals.

The other players in the value chain include Agensys, Inc., Concortis Biotherapeutics, Sanofi S.A., Celldex Therapeutics Inc., and Synthon Holding B.V.

Key Benefits :

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the antibody drug conjugates market.

Antibody Drug Conjugates Market Key Segments:

By Drugs

  • Adcetris
  • Kadcyla

By Mechanism Of Action

  • CD30 Antibodies
  • HER2 Antibodies

By Application

  • Breast Cancer
  • Lymphoma

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • The Netherlands
    • Norway
    • Russia
    • Sweden
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Chile
    • Columbia
    • Egypt
    • Iran
    • Israel
    • Turkey
    • Venezuela
    • Rest of LAMEA
 

Loading Table Of Content...


 
 

Antibody drug conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. Globally, in 2012 there were around 14.1 million cancer cases reported as per the data provided by the Cancer Research UK. The antibody drug conjugate market exhibits massive potential in the near future owing to the increase in prevalence of cancer across geographies. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market. Increase in demand from underdeveloped countries for cost-effective and efficient cancer treatment medication is further expected to boost the ADC’s market during the forecast period. Moreover, unhealthy urban lifestyle increases the risk of various diseases and surge in reported incidences of cancer is likely to fuel the demand of ADC’s in the study period.

Kadcyla is expected to account for largest market share in 2016 Owing to high prevalence of breast cancer while Adcetris is expected to grow at the highest rate during 2017-2023. In 2016, the breast cancer segment accounts for largest market share in the application area due to high number of reported cases of breast cancer globally.

North America accounted for major market share in the global ADC’s market in 2016 owing to high adoption of ADC’s and substantial purchasing power of the patient populace in the region. European region demonstrates somewhat similar potential and is reported to be the second largest ADCs market on the global platform. Asia-Pacific and LAMEA are expected to offer lucrative opportunities to market players in the near future. Countries, such as Brazil, India, China, and few others, are expected to pose as lucrative investment destinations for manufacturers of ADCs.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample

Purchase Full Report of
Antibody Drug Conjugates Market

Start reading instantly.
This Report and over 19,272+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Sep 2018 - Sep 2019)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2018 - Sep 2019)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2018 - Sep 2019)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2018 - Sep 2019)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2018 - Sep 2019)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers